Feb 16, 2023 / 09:30PM GMT
Operator
Hello, ladies and gentlemen, and welcome to the TFF Pharmaceuticals' 2023 Corporate Update Conference Call. As a reminder, this conference is being recorded. (Operator Instructions) I will now turn the call over to your host, Corey Davis of LifeSci Advisors. You may begin your conference.
Corey George Davis - LifeSci Advisors, LLC - Relationship Manager
Hello, everyone, and welcome to TFF Pharmaceuticals' Corporate Update Conference Call.
With me on the line this afternoon is Dr. Harlan Weisman, Chief Executive Officer of TFF Pharmaceuticals; Dr. Zamaneh Mikhak, Chief Medical Officer; Kirk Coleman, Chief Financial Officer; and Bill Begien, Vice President of Investor Relations.
We'll start with a disclaimer about forward-looking statements that may be made in this call and that these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from the statements made. Factors that could cause actual results to differ are described in all our filings with the U.S.
TFF Pharmaceuticals Inc To Host Investor Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers